Skip to main content

Table 1 Taxonomy of implementation outcomes

From: Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study

  

Level of analysis (measurement)

Outcome

Definition

Consumer level

Healthcare provider level

Setting level

Acceptability

Stakeholder perception that Athena is acceptable

What needs to change in Athena design and delivery?

What needs to change in Athena design and delivery?

Acceptability of Athena delivery of integrated PrEP/MOUD

Adoption

Intention to employ Athena in practice

Interaction time/frequency and quality

Barriers/facilitators to staff using Athena for WICL in each setting

Barriers/facilitators to using Athena for WICL in each setting

Feasibility

Extent to which Athena can be successfully used in settings serving WICL

Logistical constraints and structural barriers to Athena

Logistical constraints and structural barriers to Athena

Logistical constraints and structural barriers to Athena

Fidelity

Degree to which Athena was implemented as planned

Was Athena delivered as intended?

Was Athena delivered as intended? Athena clinicians will complete pre-session checklists and post-session quality assurance forms

 

Implementation cost

Cost of implementing Athena to promote sustainability

Social (stigma), economic cost of participation in Athena

Time, staffing cost of providing Athena

Economic cost of delivering Athena (e.g., reimbursement concerns)

Penetration/Reach

Integration of Athena within settings serving WICL

Recruitment rate; Completion rate; reasons for nonparticipation

Clinician agreement to recommend Athena in settings serving WICL

Administrators’ agreement to employ Athena in settings serving WICL

Sustainability potential

Extent to which Athena becomes institutionalized or is used continuously after study completion in settings serving WICL

What are barriers to Athena continuation after study completion? What would need to change to continue Athena?

What gets in the way of incorporating Athena into current clinical practice and what would need to change?

What are the barriers to scaling up and out Athena beyond the current study?

Sustainment measurement system scale

  1. WICL = women in the criminal legal system
  2. MOUD = medications for opioid use disorder